Investigating the precision of CRISPR-Cas9 systems in targeting specific loci associated with insulin resistance. By modeling hereditary Type-2 Diabetes pathways, we aim to understand the potential for therapeutic gene correction while minimizing off-target effects.
"Scientists have a responsibility to ensure that gene editing techniques are used for the greater good." — Jennifer Doudna
I am interning under Dr. Joshua Chadwick, a Scientist-C at ICMR-NIE, as part of the ICMR-DPCI initiative within the Non-Communicable Disease Division. My work primarily focuses on Public Health, POCT Devices, and, specifically, type 2 diabetes epidemiology.
Observed and documented a diverse range of endocrine cases, including Type 1, Type 2, and complex gestational diabetes. Gained exposure to patient care across all age groups.
Participated in a clinical research study on Prolonged Hepatitis A with Acute Liver Injury. Contributed comprehensive medical records to support research investigating multiple bilirubin peaks.